Q2 Results Live: Pfizer's One-Time Gain Lifts Profit; SBI Asset Quality Improves; Solar Industries Profit Zooms 79%
State Bank of India is in focus in a quarterly results development.
· NDTV Profit
A packed earnings calendar awaits investors, with heavyweight names including SBI, NSE, Bajaj Finserv, MCX, Lupin, Solar Industries, Emcure Pharmaceuticals and Bata India set to unveil their quarterly scorecards.
The analysis
State Bank of India reported movement of 79%. Those are the figures as filed — what moves the price is how they sit against what the market already expected, not their absolute size.
Against that, the stock is -1.7% on the day at ₹970.25, and has returned -7.2% over three months. It sits 21% below its 52-week high. The banks sector has moved -7.4% over the same period, so State Bank of India is running 0.2 points ahead of its peers.
For State Bank of India, the question is how much of this is already reflected in the price and how much re-rates the banks peer set alongside it.
Why it matters
- Earnings versus expectations is what actually re-rates a stock; the surprise matters more than the absolute number.
- The shift to renewables is redrawing which energy names are structural winners versus stranded.
- With NSE involved, this carries a regulatory dimension that can outlast the immediate market reaction.
Market context
- The 5 companies named span 5 sectors, so these are separate company stories rather than one sector-wide move.
- On the day, 4 of 5 are higher: Emcure Pharmaceuticals leads at +4.9% and State Bank of India (SBI) trails at -1.7%.
- Over three months: State Bank of India (SBI) -7.2% against Banks -7.4% (0.2 points ahead); Solar Industries India +5.3% against Defence & Aerospace -0.9% (6.2 points ahead); Bajaj Finserv -18.0% against Financial Services -14.5% (3.5 points behind); Emcure Pharmaceuticals +0.3% against Pharma & Healthcare -0.8% (1.1 points ahead).
- At least 25% below the 52-week high: Bata India (39%).
- Trading well above normal today: State Bank of India (SBI) at 2.8 times its 20-day average volume, Solar Industries India at 3.8 times its 20-day average volume and Emcure Pharmaceuticals at 6.8 times its 20-day average volume.
| Company | Price | Day | 1M | 3M | From 52-wk high | Volume vs 20-day | Market cap |
|---|---|---|---|---|---|---|---|
| State Bank of India (SBI)SBIN · Banks | ₹970.25 | -1.7% | +1.7% | -7.2% | -21.0% | 2.8× | — |
| Solar Industries IndiaSOLARINDS · Defence & Aerospace | ₹19,654.00 | +1.1% | +1.3% | +5.3% | -12.5% | 3.8× | — |
| Bajaj FinservBAJAJFINSV · Financial Services | ₹1,718.10 | +1.6% | -0.8% | -18.0% | -18.9% | 1.1× | — |
| Emcure PharmaceuticalsEMCURE · Pharma & Healthcare | ₹1,976.60 | +4.9% | +1.6% | +0.3% | -1.6% | 6.8× | — |
| Bata IndiaBATAINDIA · Consumer & Retail | ₹649.80 | +1.9% | +6.0% | -8.4% | -39.3% | 0.8× | — |
Banks
1M -2.7% · 3M -7.4%
State Bank of India (SBI)
Defence & Aerospace
1M -2.5% · 3M -0.9%
Solar Industries India
Financial Services
1M -4.6% · 3M -14.5%
Bajaj Finserv
Pharma & Healthcare
1M +0.9% · 3M -0.8%
Emcure Pharmaceuticals
Prices as of 3 Nov 2026, 16:10 IST. Sector moves are the average of the stocks we track in each sector.
In this story
Related coverage
Q2 Results Live: Zydus Wellness Swings To Profit; SBI, NSE Earnings In Focus
Stocks to watch: ITC, Lupin, NBCC, SBI, Dr Reddy's, Bosch, Ola Electric
Solar Industries Q2 earnings: Net profit rises 80%, revenue crosses Rs 3,500-crore mark
Stocks in news: ITC, Marico, SBI, Yatra Online, NSE, Container Corp and Sun Pharma
Bajaj Finserv Q2 Results: Profit Rises 23% To Rs 2,758 Crore, Total Income Up 17%